Jewish Telegraphic Agency2d
The Jewish story behind ‘Oppenheimer,’ explained
(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...
‘Wonka,’ ‘Dune 2,’ ‘Oppenheimer’ Drive U.K. Home Entertainment to Record $6.4 Billion Year
British consumers’ appetite for home entertainment reached new heights in 2024, with the sector surpassing £5.1 billion ($6.4 ...
Alumis draws Outperform at Oppenheimer on valuation disconnect
Oppenheimer launched its coverage of Alumis (NASDAQ:ALMS) with an Outperform recommendation and a 12–18-month price target of ...
Trump's Mass Deportation Plans Attacked in Home State Newspaper: 'Insane'
Andres Oppenheimer, a columnist for the "Miami Herald," said the Trump administration is targeting illegal immigrants with ...
Oscar Nominee Joshua Oppenheimer Worries His ‘Home Country Is Becoming a Dictatorship' But It's Not ‘The End' Just Yet: ‘Above You, There's Still a Sky'
U.S. filmmaker Joshua Oppenheimer, now based in Denmark, worries his "home country is perhaps becoming a dictatorship." "It ...
cryptopolitan on MSN1d
Oppenheimer downgrades Apple, cites weakening iPhone sales and AI innovation worries
Oppenheimer downgraded Apple from "outperform" to "perform" because it is struggling to adapt to a competitive AI landscape.
Why Alumis (ALMS) Stock Is Advancing Today
Drug maker Alumis (ALMS) is climbing 7% after investment bank Oppenheimer started coverage of the name with an Outperform ...
Ovid Therapeutics upgraded at Oppenheimer as OV329’s promise ‘quite real’
Oppenheimer upgraded Ovid Therapeutics (OVID) to Outperform from Perform with a $4 price target The firm says OV329’s promise is “quite real” ...